SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

NowRx, Inc. – ‘C-TR’ on 4/26/19

On:  Friday, 4/26/19, at 10:39am ET   ·   Accession #:  1644600-19-9   ·   File #:  20-23274

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/26/19  NowRx, Inc.                       C-TR                   1:3K                                     1644600

Crowdfunding Termination of Reporting   —   Form C-TR   —   Reg. Crowdfunding
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: C-TR        Crowdfunding Termination of Reporting --            HTML      4K 
                          primary_doc.xml                                        




        

This ‘C-TR’ Document is an XML Data File that may be rendered in various formats:

  Form C    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Termination of Reporting
 
schemaVersion:

Form C: Filer Information

Filer CIK:
0001702206 
Filer CCC:
XXXXXXXX 
Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

NowRx, Inc. 

Legal Status of Issuer:

Form:

Corporation 

Jurisdiction of Incorporation/Organization:

DELAWARE  

Date of Incorporation/Organization:

2/19/15 

Physical Address of Issuer:

Address 1:

2224 OLD MIDDLEFIELD WAY 

City:

MOUNTAIN VIEW 

State/Country:

CALIFORNIA  

Mailing Zip/Postal Code:

94043 

Website of Issuer:

www.nowrx.com 

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

NowRx, Inc. 

Signature:

Cary Breese 

Title:

CEO 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Cary Breese 

Title:

CEO 

Date:

4/26/19 


Top
Filing Submission 0001644600-19-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:46:11.1am ET